Carcinoma, Renal Cell

Showing 51 - 75 of 185

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Renal Cell Trial in Philadelphia (Pazopanib, DCE-MRI and Quantitative Doppler Ultrasound)

Completed
  • Carcinoma, Renal Cell
  • Pazopanib
  • DCE-MRI and Quantitative Doppler Ultrasound
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 25, 2020

KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and

Completed
  • Carcinoma, Renal Cell
    • Odense C, Odense, Denmark
      Odense University Hospital
    Mar 3, 2020

    Carcinoma, Renal Cell Trial in United Kingdom, United States (Pazopanib, MK-3475)

    Completed
    • Carcinoma, Renal Cell
    • Boston, Massachusetts
    • +5 more
    Feb 28, 2020

    Kidney Tumors, Carcinoma, Renal Cell Trial in Bordeaux (Anxiety, renal anatomy and surgery questionnaires)

    Withdrawn
    • Kidney Neoplasms
    • Carcinoma, Renal Cell
    • Anxiety, renal anatomy and surgery questionnaires
    • Bordeaux, France
      CHU de Bordeaux
    Jan 22, 2020

    Carcinoma, Renal Cell, Prostatic Tumors Trial in United Kingdom, United States (FK228 (romidepsin))

    Completed
    • Carcinoma, Renal Cell
    • Prostatic Neoplasms
    • FK228 (romidepsin)
    • Duarte, California
    • +4 more
    Nov 14, 2019

    Melanoma, Carcinoma, Renal Cell Trial run by the NCI (rh IL-15)

    Completed
    • Melanoma
    • Carcinoma, Renal Cell
    • rh IL-15
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 7, 2019

    Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Russian Federation (axitinib)

    Completed
    • Carcinoma, Renal Cell
    • Clear Cell Renal Cell Carcinoma
    • Irkutsk, Russian Federation
    • +14 more
    Oct 18, 2019

    Carcinoma, Renal Cell, Tumor Metastasis Trial in Duarte, Chicago, Seattle (FK228 (romidepsin))

    Completed
    • Carcinoma, Renal Cell
    • Neoplasm Metastasis
    • FK228 (romidepsin)
    • Duarte, California
    • +2 more
    Oct 16, 2019

    Carcinoma, Renal Cell Trial in Australia, Korea, Republic of (Pazopanib followed by everolimus)

    Terminated
    • Carcinoma, Renal Cell
    • Pazopanib followed by everolimus
    • Garran, Australian Capital Territory, Australia
    • +14 more
    Sep 20, 2019

    NSCLC, Carcinoma, Renal Cell, Melanoma Trial in Singapore (rSIFN-co)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • Singapore, Singapore
      National Cancer Centre Singapore
    Sep 25, 2019

    Response to Systemic Treatments in Renal Cell Cancer

    Unknown status
    • Carcinoma, Renal Cell
    • Laboratory analysis of samples
    • Application of machine learning
    • (no location specified)
    Aug 16, 2019

    NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • +7 more
    • Birmingham, Alabama
    • +10 more
    Jul 17, 2019

    Carcinoma, Renal Cell, Melanoma Trial in Charlottesville (Pembrolizumab, Interleukin-2)

    Withdrawn
    • Carcinoma, Renal Cell
    • Melanoma
    • Charlottesville, Virginia
      University of Virginia Cancer Center
    Jul 9, 2019

    Metastatic Renal Cell Carcinoma Who Have Progressed After

    Withdrawn
    • Carcinoma, Renal Cell
    • Not applicable - blood tests/tissue specimen tests will be undertaken
    • Kelowna, British Columbia, Canada
    • +2 more
    Jul 9, 2019

    Carcinoma, Renal Cell Trial in Ann Arbor (Pazopanib, Low Fat Diet)

    Completed
    • Carcinoma, Renal Cell
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Mar 8, 2019

    Carcinoma, Renal Cell Trial in Japan (AG-013736)

    Completed
    • Carcinoma, Renal Cell
    • Kashiwa, Chiba, Japan
    • +17 more
    May 22, 2019

    Advanced Renal Cell Carcinoma, With Failure or Unsuitable on

    Terminated
    • Carcinoma, Renal Cell
    • Sorafenib (Nexavar, BAY43-9006)
    • (no location specified)
    Jun 2, 2019

    Carcinoma, Renal Cell Trial in Indianapolis (Sonatherm 600i ablation system)

    Completed
    • Carcinoma, Renal Cell
    • Sonatherm 600i ablation system
    • Indianapolis, Indiana
      IU Health University Hospital
    Mar 21, 2019

    Carcinoma, Renal Cell Trial in Chiba, Tokyo (Lenvatinib, Everolimus)

    Completed
    • Carcinoma, Renal Cell
    • Chiba, Japan
    • +2 more
    Mar 7, 2019

    Carcinoma, Renal Cell Trial in Worldwide (Pazopanib)

    Completed
    • Carcinoma, Renal Cell
    • Duarte, California
    • +18 more
    Mar 4, 2019

    Follow up After Cryoablation of Small Renal Masses.

    Completed
    • Carcinoma, Renal Cell
    • 111In-Girentuximab DOTA SPECT
    • Nijmegen, Netherlands
      Radboud University Medical Center
    Jan 9, 2019

    Carcinoma, Renal Cell, Vaccination, Secondary Trial in Meldola (FC) (radiation, biological, drug)

    Withdrawn
    • Carcinoma, Renal Cell
    • +2 more
    • boost radiotherapy (XRT)
    • +2 more
    • Meldola (FC), FC, Italy
      UO Immunoterapia e Laboratorio TCS, IRCCS IRST
    Nov 8, 2018

    Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)

    Terminated
    • Carcinoma, Renal Cell
    • Houston, Texas
      UTHealth Memorial Hermann Cancer Center
    Sep 12, 2018

    Advanced Renal Cell Carcinoma

    Unknown status
    • Carcinoma, Renal Cell
      • Göteborg, Sweden
        Sahlgrenska University Hospital
      Oct 8, 2018